4 completed, 1 terminated, 1 unknown, 1 withdrawn. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 4, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Falciparum Malaria: new trials by email Literature Review of Falciparum Malaria trials Research Report on Falciparum Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers ZY19489 + Ferroquine (FQ), Placebo - Uncomplicated Malaria, Asymptomatic Condition | Phase 1 | Unknown | Zydus Lifesciences Limited | 36 | 2024-08-30 | 2024-10-01 |
| Nitrite Infusion in Children With Malaria Sodium Nitrite - Falciparum Malaria | Phase 1 | Withdrawn | Duke University | 2021-06-01 | 2021-03-16 | |
| Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects Artesunate (Test), Artesunate (Comparator) - Falciparum Malaria | Phase 1 | Completed | Pfizer | 40 | 2009-06-01 | 2010-06-25 |
| A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects Amodiaquine (Test), Amodiaquine (Comparator) - Falciparum Malaria | Phase 1 | Completed | Pfizer | 38 | 2009-06-01 | 2010-04-21 |
| Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania PEV 301& 302 in virosomes, Inflexal V (active comparator) - Falciparum Malaria | Phase 1 | Completed | Swiss Tropical & Public Health Institute | 50 | 2008-01-01 | 2013-03-15 |
| Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria Rosiglitazone, Placebo - Falciparum Malaria | Phase 1 / Phase 2 | Completed | Mahidol University | 140 | 2004-12-01 | 2015-04-13 |
| Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides Virosome-formulated synthetic peptides (malaria vaccine) - Falciparum Malaria | Phase 1 | Terminated | Swiss Tropical & Public Health Institute | 46 | 2003-11-01 | 2006-11-16 |
Malaria, Falciparum (7) · Malaria (4) · Asymptomatic Diseases (1) · Communicable Diseases (1)
Infections (7) · Mosquito-Borne Diseases (7) · Parasitic Diseases (7) · Protozoan Infections (7) · Vector Borne Diseases (7) · Malaria (3) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Amodiaquine (1) · Artesunate (1) · Inflexal V (1) · Malaria Vaccines (1) · Rosiglitazone (1) · Sodium Nitrite (1) · Virosomes (1) · ZY-19489 (1) · ferroquine (1)
Pfizer (2) · Swiss Tropical & Public Health Institute (2) · Duke University (1) · Mahidol University (1) · Zydus Lifesciences Limited (1)
Singapore (2) · Tanzania (2) · Gabon (1) · Thailand (1)
Blaise Genton, MD PhD (2) · Dr. Deven Parmar, MD,FCP (1) · Kevin C Kain, MD, FRCPC (1)
PMID 17925866, PMID 18060072, PMID 19673614, PMID 21799810
R01HL130763 (1)